The Failure of Pulmonary Oxygen Exchange in Severe Viral Lung Disease: Pneumolysis
Oxygen · 27.03.2026 · 6 (2) · 7
DOI: 10.3390/oxygen6020007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oxygen, online erschienen am 27.03.2026. Verfasst von Gustavo Zubieta-Calleja und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Severe lung compromise from COVID-19, ARDS, and recently AH3N2 can progress to life-threatening hypoxia. Past experience led to standardized protocols that assumed similarity to SARS-CoV.
Methods
COVID-19 pathophysiology and histopathological lung biopsy photomicrographs are analyzed.
Results
Pneumolysis is defined as progressive alveolar–capillary destruction resulting from SARS-CoV-2 attack on pneumocytes. In the final stages preceding pneumolysis, molecular mechanisms in the lungs include apoptosis in alveolar epithelial type I and II cells, compromising alveolar regeneration, and necrosis, resulting in leakage of intracellular contents and amplifying inflammation. Pyroptosis, driven by inflammasome activity, further disrupts alveolar integrity in ARDS. Histopathological findings include Masson bodies, alveolar-coating cells with nuclear atypia, reactive pneumocytes and reparative fibrosis, intra-alveolar hemorrhage, moderate inflammatory infiltrates and abscesses, microthrombi, hyaline membrane remnants, and emphysema. The three theoretical pathophysiological stages of progressive hypoxemia (silent hypoxemia, gasping, and death zone) are shown.
Conclusions
Silent hypoxemia rapidly progresses to critical hypoxemia. This progression results from progressive pneumolysis, inflammation, immune overexpression, autoimmunity, and HAPE-type edema, leading to acute pulmonary insufficiency. Long-lasting COVID-19 can result in fibrosis and, as a compensatory mechanism, polierythrocythemia. The proposed treatment (based on tolerance to hypoxia and the hemoglobin factor) includes prompt oxygen administration, control of inflammatory and immune responses, antibiotics, rehydration, erythropoietin and platelet aggregation inhibitors.
Zitieren
APA
Zubieta-Calleja, G., Montelongo, F. D. J., Sanchez, M. G. R., Samaja, M., & Zubieta-DeUrioste, N. (2026). The Failure of Pulmonary Oxygen Exchange in Severe Viral Lung Disease: Pneumolysis. Oxygen, 6(2), 7. https://doi.org/10.3390/oxygen6020007
Vancouver
Zubieta-Calleja G, Montelongo FDJ, Sanchez MGR, Samaja M, Zubieta-DeUrioste N. The Failure of Pulmonary Oxygen Exchange in Severe Viral Lung Disease: Pneumolysis. Oxygen. 2026;6(2):7. doi:10.3390/oxygen6020007
BibTeX
@article{ZubietaCalleja2026,
author = {Zubieta-Calleja, Gustavo and Montelongo, Felipe de Jesús and Sanchez, Manuel Gabriel Romo and Samaja, Michele and Zubieta-DeUrioste, Natalia},
title = {The Failure of Pulmonary Oxygen Exchange in Severe Viral Lung Disease: Pneumolysis},
journal = {Oxygen},
year = {2026},
volume = {6},
number = {2},
pages = {7},
doi = {10.3390/oxygen6020007}
}
EUVIMED